Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling.

International journal of molecular sciences·2026
Same author

Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response.

Journal for immunotherapy of cancer·2026
Same author

An enhancement of extrachromosomal circular DNA enrichment and amplification to address the extremely low overlap between replicates.

The Journal of biological chemistry·2026
Same author

Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models.

Frontiers in immunology·2025
Same author

Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy response.

bioRxiv : the preprint server for biology·2025
Same author

An Enhancement of Extrachromosomal Circular DNA Enrichment and Amplification to Address the Extremely Low Overlap Between Replicates.

bioRxiv : the preprint server for biology·2025

Related Experiment Videos

Carbamylated LDL.

Alexei G Basnakian1, Sudhir V Shah, Ercan Ok

  • 1Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. basnakianalexeig@uams.edu

Advances in Clinical Chemistry
|September 23, 2010
PubMed
Summary

Protein carbamylation, a nonenzymatic modification, is linked to atherosclerosis. Carbamylated low-density lipoprotein (cLDL) is elevated in kidney disease patients and promotes cardiovascular disease progression.

Related Experiment Videos

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Nephrology

Background:

  • Nonenzymatic protein modification, specifically carbamylation, is gaining attention for its role in atherosclerosis.
  • Carbamylation of low-density lipoprotein (LDL) is a key mechanism affecting individuals with high cardiovascular risk, particularly those with renal insufficiency (elevated urea) or tobacco smoking (elevated thiocyanate).

Purpose of the Study:

  • To investigate the role of carbamylated LDL (cLDL) in atherosclerosis.
  • To explore the cytotoxic effects and cellular interactions of cLDL.
  • To identify potential therapeutic targets for atherosclerosis.

Main Methods:

  • The study focuses on the presence and effects of carbamylated LDL (cLDL) in relevant patient populations and in vitro models.
  • In vitro studies assessed the cytotoxic effects of cLDL on endothelial cells, adhesion molecule expression, and monocyte adhesion.
  • Vascular smooth-muscle cell (VSMC) proliferation was also examined in relation to cLDL.

Main Results:

  • Carbamylated LDL (cLDL) levels are elevated in patients with end-stage kidney disease, particularly those with atherosclerosis.
  • In vitro, cLDL demonstrated cytotoxic effects on endothelial cells, increased adhesion molecule expression, and aggravated monocyte adhesion.
  • cLDL was found to facilitate vascular smooth-muscle cell (VSMC) proliferation.

Conclusions:

  • Carbamylation of LDL is a significant factor in atherosclerosis, especially in patients with kidney disease or smokers.
  • cLDL exhibits pro-atherosclerotic properties, including endothelial cell damage and promotion of vascular cell proliferation.
  • Further research into pharmacological interruption of these pathways may yield novel atherosclerosis therapies.